BILN-2061
|
|
BILN-2061 Eigenschaften
- Dichte
- 1.37
- L?slichkeit
- Soluble in DMSO
- Aggregatzustand
- Powder
- pka
- 3.32±0.60(Predicted)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alarmwort | Warnung | |||||||||||||||||||||||||||||||||||
| Gefahrenhinweise |
|
|||||||||||||||||||||||||||||||||||
| Sicherheit |
|
BILN-2061 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Treatment of Hepatitis C infection.BILN-2061 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
BILN-2061 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 24)Lieferanten
| Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 |
marketing@targetmol.com | United States | 32466 | 58 |
| Baoji Guokang Healthchem Co., Ltd. | +86-0917-3909592 +86-13892490616 |
gksales1@gk-bio.com | China | 9066 | 58 |
| BOC Sciences | 16314854226; +16314854226 |
inquiry@bocsci.com | United States | 19853 | 58 |
| Amadis Chemical Company Limited | 571-89925085 |
sales@amadischem.com | China | 131956 | 58 |
| Chembest Research Laboratories Limited | 021-20908456 |
sales@BioChemBest.com | China | 6002 | 61 |
| AdooQ BioScience, LLC | +1 (866) 930-6790 |
info@adooq.com | United States | 2782 | 58 |
| Shanghai Tombiopharma Chemical Co. Ltd. | 13391076197 |
tombiopharma@163.com | China | 4987 | 55 |
| AdooQ Bioscience CHINA | 025-58849295 18951903616; |
info@adooq.cn | China | 2990 | 60 |
| LETOPHARM LIMITED | +86-21-5821 5861 |
sales@letopharm.com | China | 2384 | 58 |
| Tcichem, Inc. | 13918644899 |
81587635@qq.com | China | 1994 | 55 |
- BILN-2061
- BILN 2061ZW
- Ciluprevir (BILN 2061,BILN 2061ZW)
- Ciluprevir (BILN 2061)
- (2R,6S,12Z,13aS,14aR,16aS)-6-[[(Cyclopentyloxy)carbonyl]amino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-2-[[7-methoxy-2-[2-[(1-methylethyl)amino]-4-thiazolyl]-4-quinolinyl]oxy]-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxylic acid
- (2R,6S,12Z,13aS,14aR,16aS)-6-[[(Cyclopentyloxy)carbonyl]amino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-2-[[7-methoxy-2-[2-[(1-methylethyl)amino]-4-thiazolyl]-4-quinolinyl]oxy]-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a
- Cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxylic acid, 6-[[(cyclopentyloxy)carbonyl]amino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-2-[[7-methoxy-2-[2-[(1-methylethyl)amino]-4-thiazolyl]-4-quinolinyl]oxy]-5,16-dioxo-, (2R,6S,12Z,13aS,14aR,16aS)-
- 300832-84-2
- C40H50N6O8S




